Top Markets
#1 BCGame Coin BCGame Coin +5.93%
#2 Tornado Cash Tornado Cash +5.13%
#3 Fake World Assets Fake World Assets +3.87%
#4 StonkBroker StonkBroker +2.14%
#5 Osmosis Osmosis +2.14%
#6 AtomOne AtomOne +2.05%
#7 aPriori aPriori +1.76%
#8 Nockchain Nockchain +1.73%
#9 Ether.fi Ether.fi +1.62%
#10 BORA BORA +1.46%
Coin of the day
BCGame Coin BCGame Coin
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Recro Pharma, Inc. Recro Pharma, Inc.

Recro Pharma, Inc.

REPH
Rang in Aktien #25706
Recro Pharma, Inc. operates as a contract development and manufacturing... Recro Pharma, Inc. operates as a contract development and manufacturing organization (CDMO), offering comprehensive services for the development, production, and packaging of diverse therapeutic dosage forms. The company primarily specializes in small molecule therapeutic development, serving both domestic U.S. and international clients. Its extensive capabilities encompass a wide array of formats, including oral solid doses, sterile injectable solutions, oral liquid preparations, tablets, topical formulations, liquid/powder-filled capsules, ophthalmic droppers, liposomal products, and nano/microparticles. Furthermore, Recro Pharma provides specialized services such as aseptic fill/finish, lyophilization (freeze-drying), final packaging, and logistics management. Originally founded as Recro Pharma I, Inc., the company underwent a name change to Recro Pharma, Inc. in August 2008. The organization was established in 2007 and is headquartered in Exton, Pennsylvania.
Aktienkurs
$2.09
Zuletzt synchronisiert: 2022-03-21
Marktkapitalisierung
$47.04M
Veränderung (1 Tag)
-0.48%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Recro Pharma, Inc. (REPH)

Kategorie

Healthcare
P/S-Verhältnis für Recro Pharma, Inc. (REPH)
P/S-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Recro Pharma, Inc. beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/S-Verhältnis bei 0.
P/S-Verlauf für Recro Pharma, Inc. von 2026 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/S-Verhältnis P/S-Verhältnis-Differenz Land
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
- -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
- -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
- -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
- -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
7.73 -
IN